Commercial insight into the pharma and biotech sector.
Tired of mining clinical trial data from public sites? We do the work so you don't have to.
EvaluatePharma® is pleased to introduce 
EP Clinical Trials our new clinical trial intelligence service that links ClinicalTrials.gov¹ and EudraCT² data for faster and more efficient analysis of the global clinical trials landscape.
EP Clinical Trials is available both as a standalone subscription service and an additional module to the EvaluatePharma® service - Special introductory pricing available until 31 March 2012.
Request a Demo of EP Clinical Trials and see how it will help you be more productive and gain greater confidence in your analysis and decision-making.
- Updated daily with unrivalled access to cross-linked trial records of ClinicalTrials.gov¹ and EudraCT²
- Clinical Trials.gov coverage includes 115,000+ trials, 20,000+ linked sources, 175+ countries, 90,000+ trial investigators, 640+ Indications, mapped to 3200+ commercial companies
- EudraCT coverage includes 36,000+ country level trials, 15,000+ master trials, 7,500+ mapped to NCTID’s, 7,000+ sources, 30 EU & EEA countries, 480+ Indications, mapped to 840+ commercial companies
- EudraCT coverage also offers trial records at a country level, enrollment numbers by EU country, CAS number disclosure and trials on orphan indications identified
- Benchmark the clinical trial landscape faster to see trials being conducted and reported out with integrated, standardized clinical trial data linked to Company, Indication, Therapy Area and R&D Pipeline
- Custom alerts highlighting changes in trial data, the value and new trials launched
- Latest trial news and events plus award-winning commentary from
EP Vantage
- Easily exported to Excel or create custom PDF reports
Already an EvaluatePharma® subscriber? Contact your Account Manager for a demo today!
¹ClinicalTrials.gov, source US National Library of Medicine; ²EudraCT Public Website, source EU Clinical Trials Register